Histamine receptor type 1 (H1 receptor (or H1R))

The Histamine receptor type 1 (H1 receptor, H1R) is a member of the G protein-coupled receptor (GPCR) family, specifically rhodopsin-like receptors, that mediates the cellular effects of histamine in various tissues including smooth muscle, endothelium, and the central nervous system[1][3][5][7]. Upon activation by histamine, the H1 receptor couples to a Gq protein, triggering the phospholipase C–inositol trisphosphate (IP3) signaling cascade, resulting in increased intracellular calcium and various downstream effects such as smooth muscle contraction, increased vascular permeability, and inflammatory mediator release[1][3][7]. H1 receptors are ubiquitously expressed on nerves, vascular endothelium, smooth muscle, and immune cells, and play a critical role in mediating the classic symptoms of immediate hypersensitivity and allergic reactions, such as itching, swelling, vasodilation, bronchoconstriction, and mucous secretion[1][7]. In the central nervous system, they modulate wakefulness and the sleep-wake cycle. Pharmacological inhibition of this receptor with H1-antihistamines (either as antagonists or inverse agonists) is the principal mechanism by which a wide range of allergy and anti-inflammatory drugs exert their effect[2][5][6]. First-generation antihistamines are effective but often cause sedation due to CNS penetration, while second- and third-generation drugs are more selective for peripheral H1 receptors and have fewer sedative and anticholinergic side effects[2][4][6]. The H1 receptor crystal and cryo-EM structures have revealed key sites for drug binding and activation, aiding the design of newer, more selective therapeutic agents[3][5].

Other names

H1 receptorHistamine H1 receptorH1R

Antagonist: Blocks (inhibits) the receptor, preventing histamine-induced allergic effects. Inverse agonist: Reduces constitutive activity of the receptor even in the absence of histamine.